Precision Medicine AIT Initiatives

About Stallergenes Greer

Stallergenes Greer is a global leader in allergy therapeutics, focusing exclusively on allergen immunotherapy (AIT). The company leverages a fully integrated model spanning R&D, manufacturing, and commercialization to address a growing global allergy market. Its strategy centers on advancing precision medicine in AIT, expanding its geographic footprint, and broadening its portfolio through internal development and acquisitions, such as the recent purchase of ENTOMON S.R.L. to boost venom immunotherapy capacity.

Therapeutic Areas